Plus, news about UK clinical studies and Kura Oncology: Trevi Therapeutics to sell $150M in shares: The biotech plans to float more than 11.5 million shares at $13 apiece. Trevi is …
Every Old Vulnerability Is Now an AI Vulnerability
AI’s danger isn’t that it’s creating new bugs, it’s that it’s amplifying old ones.
Facility-Level Associations Between Use of a Digital Health Platform for Voluntary Counseling and Testing and HIV Testing Outcomes in the Urban Primary Health Care Centers of Guangzhou, China: Cross-Sectional Study
Background: WellTest, a digital health platform designed to facilitate HIV voluntary counseling and testing (VCT) services, has been widely implemented in Guangzhou, China. However, the extent of its use by primary health care centers (PHCs) and the facility-level associations between WellTest use and HIV testing outcomes remain unclear. Objective: This study aimed to assess the […]
Biovac gets $108M backing for vaccine factory in South Africa
Biovac’s new vaccine factory in Cape Town, which is expected to make up to 400 million vaccines per year, has secured financing from the European Investment Bank, the European Commission and the International Finance Corporation. …
Obesity biotech Kailera’s record-breaking IPO
When Kailera revealed its plans for an IPO last month, there was a feeling that it could be huge – and that expectation has now been fulfilled.
Revolution Medicines’ buyout price soars after pancreatic cancer win
In January, Revolution Medicines was rumored to have a $30 billion buyout offer on the table. Now, it doesn’t. Also in January, Revolution didn’t have its Phase 3 pancreatic cancer results. Now, it does. So …
Coast Guard’s New Cybersecurity Rules Offers Lessons for CISOs
The Maritime Transportation Security Act (MTSA) requires plans to protect OT systems, audits by independent third parties, and a hybrid OT-security role.
OpenAI introduces GPT-Rosalind, its drug discovery AI
In this week’s second AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, named after UK scientist Rosalind Franklin.
Kailera raises $625M IPO in biotech record
The latest biotech IPO comes in at a record high. Kailera Therapeutics raised $625 million, topping the record set by Moderna’s public entrance. In 2018, Moderna put together a $604 million IPO. Kailera is only …
Lilly’s tirzepatide sheds lean muscle harder than Novo’s semaglutide, study suggests
While Eli Lilly’s tirzepatide helps patients drop more weight than Novo Nordisk’s semaglutide, this might come with greater loss in lean body mass, according to a new study awaiting peer review. The analysis, shared as …
Novartis’ Vas Narasimhan heads to Anthropic’s board; Metsera alum joins Structure as COO
→ Anthropic keeps deepening its ties to the biopharma industry, appointing Novartis CEO Vas Narasimhan to its board. The AI giant recently acquired Coefficient Bio, a New York-based …
Multiple myeloma drug Blenrep backed for wider NHS use
The revitalisation of GSK’s Blenrep has continued with the news that the NHS in England can use the BCMA-targeting multiple myeloma drug more widely.